Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Brain Neoplasms × BID protein, human × Clear all

Sponsor

Conditions

Neoplasms 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Urinary Bladder Neoplasms 1 Solid Tumor 1 Ovarian Neoplasms 1 Neoplasms by Histologic Type 1 Neoplasm Metastasis 1 NSCLC 1 Myeloproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid 1 Leukemia 1 Hematologic Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Bone Marrow Diseases 1 Advanced Solid Tumor 1 Adenocarcinoma of Lung 1

Interventions

Temozolomide 50 Bevacizumab 42 Radiotherapy 28 Radiosurgery 18 Carboplatin 14 Erlotinib Hydrochloride 10 Radiation 9 pembrolizumab 8 Vorinostat 8 Magnetic Resonance Spectroscopy 8 Irinotecan 8 Trastuzumab 7 Radiotherapy, Intensity-Modulated 7 Etoposide 7 Capecitabine 7 Lomustine 6 Lapatinib 6 dabrafenib 5 Sunitinib 5 Sorafenib 5 Ipilimumab 5 Imatinib Mesylate 5 Everolimus 5 Cyclophosphamide 5 cabozantinib 4 binimetinib 4 Therapeutics 4 Radiotherapy, Conformal 4 NVP-BKM120 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡